Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.54
-0.035-0.46%
Last update: Dec 12, 2:35 PM
Comments
Loading...
BioCryst Pharma (BCRX) Stock Price, Quote, News & History
BCRXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioCryst Pharma (BCRX) stock?
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Who are BioCryst Pharma (BCRX) competitors?
Other companies in BioCryst Pharma’s space includes: Immunome Inc (NASDAQ:IMNM), Precigen Inc (NASDAQ:PGEN), Upstream Bio Inc (NASDAQ:UPB), Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and Immatics NV (NASDAQ:IMTX).
What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?
BioCryst Pharma has a consensus price target of $18.93.
What is the current price for BioCryst Pharma (BCRX)?
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.545 last updated December 12, 2025 at 2:35 PM EST.
Does BioCryst Pharma (BCRX) pay a dividend?
There are no upcoming dividends for BioCryst Pharma.
When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?
BioCryst Pharma does not have any upcoming earnings scheduled.
Is BioCryst Pharma (BCRX) going to split?
There is no upcoming split for BioCryst Pharma.
What sector and industry does BioCryst Pharma (BCRX) operate in?
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
